91 related articles for article (PubMed ID: 19473659)
1. Phospholipase A(2)-modified LDL particles retain the generated hydrolytic products and are more atherogenic at acidic pH.
Lähdesmäki K; Plihtari R; Soininen P; Hurt-Camejo E; Ala-Korpela M; Oörni K; Kovanen PT
Atherosclerosis; 2009 Dec; 207(2):352-9. PubMed ID: 19473659
[TBL] [Abstract][Full Text] [Related]
2. Acidity and lipolysis by group V secreted phospholipase A(2) strongly increase the binding of apoB-100-containing lipoproteins to human aortic proteoglycans.
Lähdesmäki K; Öörni K; Alanne-Kinnunen M; Jauhiainen M; Hurt-Camejo E; Kovanen PT
Biochim Biophys Acta; 2012 Feb; 1821(2):257-67. PubMed ID: 22041135
[TBL] [Abstract][Full Text] [Related]
3. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
Boyanovsky B; Zack M; Forrest K; Webb NR
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803
[TBL] [Abstract][Full Text] [Related]
4. Increased lipolysis by secretory phospholipase A(2) group V of lipoproteins in diabetic dyslipidaemia.
Pettersson C; Fogelstrand L; Rosengren B; Ståhlman S; Hurt-Camejo E; Fagerberg B; Wiklund O
J Intern Med; 2008 Aug; 264(2):155-65. PubMed ID: 18298481
[TBL] [Abstract][Full Text] [Related]
5. Differences between group X and group V secretory phospholipase A(2) in lipolytic modification of lipoproteins.
Kamitani S; Yamada K; Yamamoto S; Ishimoto Y; Ono T; Saiga A; Hanasaki K
Cell Mol Biol Lett; 2012 Sep; 17(3):459-78. PubMed ID: 22706677
[TBL] [Abstract][Full Text] [Related]
6. Acidity increases the uptake of native LDL by human monocyte-derived macrophages.
Plihtari R; Kovanen PT; Öörni K
Atherosclerosis; 2011 Aug; 217(2):401-6. PubMed ID: 21571277
[TBL] [Abstract][Full Text] [Related]
7. Bioactive products generated by group V sPLA(2) hydrolysis of LDL activate macrophages to secrete pro-inflammatory cytokines.
Boyanovsky BB; Li X; Shridas P; Sunkara M; Morris AJ; Webb NR
Cytokine; 2010 Apr; 50(1):50-7. PubMed ID: 20138782
[TBL] [Abstract][Full Text] [Related]
8. Human group X secreted phospholipase A2 induces dendritic cell maturation through lipoprotein-dependent and -independent mechanisms.
Atout R; Karabina SA; Dollet S; Carreras M; Payré C; André P; Lambeau G; Lotteau V; Ninio E; Perrin-Cocon L
Atherosclerosis; 2012 Jun; 222(2):367-74. PubMed ID: 22494626
[TBL] [Abstract][Full Text] [Related]
9. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans.
Hakala JK; Oörni K; Pentikäinen MO; Hurt-Camejo E; Kovanen PT
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1053-8. PubMed ID: 11397719
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase.
Plihtari R; Hurt-Camejo E; Oörni K; Kovanen PT
J Lipid Res; 2010 Jul; 51(7):1801-9. PubMed ID: 20124257
[TBL] [Abstract][Full Text] [Related]
11. Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans.
Boyanovsky BB; van der Westhuyzen DR; Webb NR
J Biol Chem; 2005 Sep; 280(38):32746-52. PubMed ID: 16040605
[TBL] [Abstract][Full Text] [Related]
12. Decrease in pH strongly enhances binding of native, proteolyzed, lipolyzed, and oxidized low density lipoprotein particles to human aortic proteoglycans.
Sneck M; Kovanen PT; Oörni K
J Biol Chem; 2005 Nov; 280(45):37449-54. PubMed ID: 16147996
[TBL] [Abstract][Full Text] [Related]
13. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
[TBL] [Abstract][Full Text] [Related]
14. Hydrolysis of minor glycerophospholipids of plasma lipoproteins by human group IIA, V and X secretory phospholipases A2.
Pruzanski W; Lambeau G; Lazdunski M; Cho W; Kopilov J; Kuksis A
Biochim Biophys Acta; 2007 Jan; 1771(1):5-19. PubMed ID: 17197234
[TBL] [Abstract][Full Text] [Related]
15. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions.
Ishimoto Y; Yamada K; Yamamoto S; Ono T; Notoya M; Hanasaki K
Biochim Biophys Acta; 2003 Oct; 1642(3):129-38. PubMed ID: 14572896
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase A(2) in vascular disease.
Hurt-Camejo E; Camejo G; Peilot H; Oörni K; Kovanen P
Circ Res; 2001 Aug; 89(4):298-304. PubMed ID: 11509445
[TBL] [Abstract][Full Text] [Related]
17. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.
Hakala JK; Oksjoki R; Laine P; Du H; Grabowski GA; Kovanen PT; Pentikäinen MO
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1430-6. PubMed ID: 12750117
[TBL] [Abstract][Full Text] [Related]
18. Hypersusceptibility of neutrophil granulocytes towards lethal action of free fatty acids contained in enzyme-modified atherogenic low density lipoprotein.
Lux CA; Koschinski A; Dersch K; Husmann M; Bhakdi S
Atherosclerosis; 2009 Nov; 207(1):116-22. PubMed ID: 19423111
[TBL] [Abstract][Full Text] [Related]
19. Enhanced extracellular lipid accumulation in acidic environments.
Oörni K; Kovanen PT
Curr Opin Lipidol; 2006 Oct; 17(5):534-40. PubMed ID: 16960502
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2-modified low-density lipoprotein activates the phosphatidylinositol 3-kinase-Akt pathway and increases cell survival in monocytic cells.
Namgaladze D; Brüne B
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2510-6. PubMed ID: 16973971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
